Equities
  • Price (CHF)93.54
  • Today's Change0.00 / 0.00%
  • Shares traded70.00
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Aug 08 2022.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

Philip Morris International Inc. (PMI) is an international tobacco company. The Company focuses on delivering a smoke-free future and evolving its portfolio for the long term to include products outside of the tobacco and nicotine sector. Its product portfolio consists of cigarettes and smoke-free products, including heat-not-burn, vapor and oral nicotine products, which are sold in markets outside the United States. It is engaged in developing smoke-free products for adults along with building scientific assessment capabilities in the areas of pre-clinical systems toxicology, clinical and behavioral research, as well as post-market studies. Versions of PMI's IQOS Platform 1 devices and consumables have been authorized by the U.S. Food and Drug Administration as Modified Risk Tobacco Products (MRTPs). Its portfolio consists of both international and local brands and is led by Marlboro. The Company's other cigarette brands include Bond Street, Chesterfield, L&M, Lark and Philip Morris.

  • Revenue in USD (TTM)31.80bn
  • Net income in USD9.06bn
  • Incorporated2007
  • Employees69.60k
  • Location
    Philip Morris International Inc120 Park AveNEW YORK 10017-5577United StatesUSA
  • Phone+1 (917) 663-2000
  • Websitehttps://www.pmi.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
PM:NYQ since
announced
Transaction
value
Swedish Match AB- Cigarette BusinessAnnounced15 Sep 202115 Sep 2021Announced-0.94%--
Data delayed at least 15 minutes, as of Aug 15 2022 21:10 BST.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.